| MeSH term | MeSH ID | Detail |
|---|---|---|
| Alcoholic Intoxication | D000435 | 15 associated lipids |
| Angina, Unstable | D000789 | 14 associated lipids |
| Aortic Aneurysm | D001014 | 8 associated lipids |
| Ascites | D001201 | 25 associated lipids |
| Bartter Syndrome | D001477 | 5 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Cardiovascular Diseases | D002318 | 24 associated lipids |
| Carotid Artery Thrombosis | D002341 | 7 associated lipids |
| Cerebral Hemorrhage | D002543 | 13 associated lipids |
| Cerebrovascular Disorders | D002561 | 25 associated lipids |
2,3-dinor, 6-keto-PGF1alpha
2,3-dinor, 6-keto-pgf1alpha is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 782 references associated with 2,3-dinor, 6-keto-PGF1alpha in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 2,3-dinor, 6-keto-PGF1alpha
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 2,3-dinor, 6-keto-PGF1alpha
NCBI Entrez Crosslinks
All references with 2,3-dinor, 6-keto-PGF1alpha
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Förstermann U et al. | An increase in the ratio of thromboxane A2 to prostacyclin in association with increased blood pressure in patients on cyclosporine A. | 1989 | Prostaglandins | pmid:2662262 |
| Aitokallio-Tallberg A et al. | Urinary excretion of prostacyclin and thromboxane degradation products in patients with ovarian malignancy: effect of cytostatic treatment. | 1989 | Br. J. Cancer | pmid:2803956 |
| Knapp HR and Salem N | Formation of PGI3 in the rat during dietary fish oil supplementation. | 1989 | Prostaglandins | pmid:2557651 |
| Hamazaki T et al. | Urinary excretion of PGI2/3-M and recent N-6/3 fatty acid intake. | 1989 | Prostaglandins | pmid:2503856 |
| Fitzgerald DJ et al. | Prostaglandin endoperoxides modulate the response to thromboxane synthase inhibition during coronary thrombosis. | 1988 | J. Clin. Invest. | pmid:3183064 |
| Balazy M et al. | Facile method for preparation of 2,3-dinor-6-keto PGF1 alpha, the major urinary metabolite of prostacyclin. | 1988 | Prostaglandins | pmid:3070630 |
| Vesterqvist O et al. | In vivo production of thromboxane and prostacyclin in patients following total hip arthroplasty. | 1988 | Scand. J. Clin. Lab. Invest. | pmid:3375779 |
| Wennmalm A et al. | Excretion of thromboxane A2 and prostacyclin metabolites during treadmill exercise in patients with intermittent claudication. | 1988 | Clin Physiol | pmid:3402185 |
| Gréen K et al. | Urinary metabolites of thromboxane and prostacyclin in diabetes mellitus. | 1988 | Acta Endocrinol. | pmid:3291538 |
| Alessandrini P et al. | Thromboxane biosynthesis and platelet function in type I diabetes mellitus. | 1988 | N. Engl. J. Med. | pmid:3292913 |
| Ylikorkala O et al. | Urinary prostacyclin and thromboxane metabolites in drinking pregnant women and in their infants: relations to the fetal alcohol effects. | 1988 | Obstet Gynecol | pmid:3275910 |
| Lassila R et al. | Vasoactive and atherogenic effects of cigarette smoking: a study of monozygotic twins discordant for smoking. | 1988 | BMJ | pmid:3142565 |
| Vericel E et al. | Platelets and aging. I--Aggregation, arachidonate metabolism and antioxidant status. | 1988 | Thromb. Res. | pmid:3129819 |
| Minuz P et al. | Altered excretion of prostaglandin and thromboxane metabolites in pregnancy-induced hypertension. | 1988 | Hypertension | pmid:3290103 |
| Seyberth HW et al. | Excretion of primary prostanoids and their metabolites during acute volume expansion. | 1988 | Prostaglandins | pmid:3163156 |
| Edlund A et al. | Leg exercise increases prostacyclin synthesis without activating platelets in both healthy and atherosclerotic humans. | 1987 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2959097 |
| Ciabattoni G et al. | Radioimmunoassay measurement of 2,3-dinor metabolites of prostacyclin and thromboxane in human urine. | 1987 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2960163 |
| Castagnoli MN et al. | Combined high-performance liquid chromatography and enzyme immunoassay for the determination of urinary metabolites of thromboxane and 6-keto-PGF1 alpha. | 1987 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2960164 |
| Vesterqvist O et al. | Synthetic arterial grafts cause prolonged increase in the in vivo formation of thromboxane and prostacyclin in humans. | 1987 | Res Exp Med (Berl) | pmid:3303204 |
| Förstermann U and Feuerstein TJ | Decreased systemic formation of prostaglandin E and prostacyclin, and unchanged thromboxane formation, in alcoholics during withdrawal as estimated from metabolites in urine. | 1987 | Clin. Sci. | pmid:3308287 |